Kunitomo Watanabe

3.3k total citations
127 papers, 2.6k citations indexed

About

Kunitomo Watanabe is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Kunitomo Watanabe has authored 127 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 37 papers in Infectious Diseases and 33 papers in Clinical Biochemistry. Recurrent topics in Kunitomo Watanabe's work include Bacterial Identification and Susceptibility Testing (33 papers), Clostridium difficile and Clostridium perfringens research (23 papers) and Antibiotic Resistance in Bacteria (17 papers). Kunitomo Watanabe is often cited by papers focused on Bacterial Identification and Susceptibility Testing (33 papers), Clostridium difficile and Clostridium perfringens research (23 papers) and Antibiotic Resistance in Bacteria (17 papers). Kunitomo Watanabe collaborates with scholars based in Japan, United States and Indonesia. Kunitomo Watanabe's co-authors include Naoki Kato, Haru Kato, Kazue Ueno, Kaori Tanaka, Yuli Song, Kanzo Suzuki, Mamoru Koketsu, Toshinobu Yamamoto, N Iwai and H Nakamura and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Kunitomo Watanabe

122 papers receiving 2.5k citations

Peers

Kunitomo Watanabe
Comparison fields: 5 of 118
  • Infectious Diseases 862
  • Molecular Biology 839
  • Epidemiology 669
  • Food Science 438
  • Clinical Biochemistry 365
Replace Bruna Facinelli with:
Bruna Facinelli Italy
Maria Santagati Italy
E. Anne Eady United Kingdom
L. Dubreuil France
Alban Le Monnier France
Jonathan H. Cove United Kingdom
D. van der Waaij Netherlands
Kerin L. Tyrrell United States
Kátia Regina Netto dos Santos Brazil
Robert Rennie Canada
Bruna Facinelli Italy View profile →
Citations per field, relative to Kunitomo Watanabe
Kunitomo Watanabe · 1×
Citations per year, relative to Kunitomo Watanabe
Kunitomo Watanabe · 1×

Countries citing papers authored by Kunitomo Watanabe

Since Specialization
Citations

This map shows the geographic impact of Kunitomo Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunitomo Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunitomo Watanabe more than expected).

Fields of papers citing papers by Kunitomo Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunitomo Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunitomo Watanabe. The network helps show where Kunitomo Watanabe may publish in the future.

Co-authorship network of co-authors of Kunitomo Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Kunitomo Watanabe. A scholar is included among the top collaborators of Kunitomo Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunitomo Watanabe. Kunitomo Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 7
2 2
3 60
4 38
5
Comparative study on sitafloxacin and levofloxacin in complicated urinary tract infections
8
6 12
7 98
8
Study on the Association between the Patients' Clinical Background and the Anaerobes by Data Mining In Infectious Diseases Database
4
9
The in vitro activity of pazufloxacin, a new orally quinolone, against anaerobic bacteria
1
10 5
11 3
12
In vitro antibacterial activity of novel cephalosporin, cefozopran, against anaerobic bacteria
1
13
ANTIBACTERIAL ACTIVITY OF LEVOFLOXACIN, S -ISOMER OF OFLOXACIN, AGAINST ANAEROBIC BACTERIA
2
14 14
15 5
16
The effect of cefixime on bacterial flora in the intestinal tracts of healthy male volunteers
1
17
In vitro activity of DL-8280 against anaerobic bacteria
3
18
[Antibacterial activity of sulfobenzylpenicillin against anaerobic bacteria (author's transl)].
1
19 1
20
SUSCEPTIBILITY OF ANAEROBIC BACTERIA TO LINCOMYCIN AND CLINDAMYCIN
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026